$454 Million is the total value of Eagle Health Investments LP's 23 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 14.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ICLR | ICON PLC | $45,851,750 | -1.6% | 186,200 | 0.0% | 10.10% | +16.0% | |
| DHR | Buy | DANAHER CORPORATION | $43,438,589 | +5.2% | 175,085 | +1.7% | 9.57% | +24.0% |
| IQV | Sell | IQVIA HLDGS INC | $40,549,191 | -17.8% | 206,095 | -6.1% | 8.94% | -3.1% |
| UTHR | UNITED THERAPEUTICS CORP DEL | $38,587,179 | +2.3% | 170,838 | 0.0% | 8.50% | +20.6% | |
| ARGX | ARGENX SEsponsored adr | $31,660,972 | +26.1% | 64,400 | 0.0% | 6.98% | +48.6% | |
| LNTH | Buy | LANTHEUS HLDGS INC | $28,952,316 | +36.3% | 416,700 | +64.6% | 6.38% | +60.6% |
| NTRA | NATERA INC | $26,359,460 | -9.1% | 595,694 | 0.0% | 5.81% | +7.2% | |
| DXCM | Buy | DEXCOM INC | $25,760,597 | +23.4% | 276,105 | +70.0% | 5.68% | +45.5% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $24,219,488 | -6.8% | 136,756 | 0.0% | 5.34% | +9.9% | |
| TMDX | Buy | TRANSMEDICS GROUP INC | $22,677,724 | +16.4% | 414,205 | +78.5% | 5.00% | +37.2% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $21,117,979 | +89.4% | 174,212 | +79.0% | 4.65% | +123.3% |
| INSP | Buy | INSPIRE MED SYS INC | $18,503,141 | -21.8% | 93,243 | +28.0% | 4.08% | -7.8% |
| OM | Buy | OUTSET MED INC | $16,260,312 | -38.1% | 1,494,514 | +24.5% | 3.58% | -27.0% |
| ILMN | Sell | ILLUMINA INC | $16,185,587 | -47.8% | 117,902 | -28.7% | 3.57% | -38.5% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $12,682,463 | -57.5% | 43,390 | -50.3% | 2.80% | -49.9% |
| PROCEPT BIOROBOTICS CORP | $11,064,123 | -7.2% | 337,218 | 0.0% | 2.44% | +9.4% | ||
| AGIO | AGIOS PHARMACEUTICALS INC | $6,623,843 | -12.6% | 267,630 | 0.0% | 1.46% | +3.0% | |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $6,620,987 | -18.8% | 1,214,860 | 0.0% | 1.46% | -4.3% | |
| GH | Sell | GUARDANT HEALTH INC | $6,072,080 | -61.9% | 204,861 | -54.0% | 1.34% | -55.1% |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $5,574,607 | -29.6% | 437,911 | 0.0% | 1.23% | -17.0% | |
| PNT | POINT BIOPHARMA GLOBAL INC | $2,041,967 | -26.4% | 306,142 | 0.0% | 0.45% | -13.3% | |
| CMAX | CAREMAX INC | $1,515,281 | -31.8% | 714,755 | 0.0% | 0.33% | -19.7% | |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $1,507,399 | -52.6% | 579,769 | -14.8% | 0.33% | -44.1% |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -1,395,039 | -100.0% | -0.55% | – |
| CANO | Exit | CANO HEALTH INC | $0 | – | -4,290,901 | -100.0% | -1.12% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -320,325 | -100.0% | -1.47% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -459,621 | -100.0% | -3.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.